Gold Daniel Allen's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Dec 18, 2025
- Accession no.
- 0001193125-25-325359
- Filed
- Dec 18, 2025
- Trade date
- Dec 16-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $39.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gold Daniel AllenCIK 0001832142 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Common Shares | SSaleDisposed | −275,000 | $22.93 | −$6,305,750 | 17,772,727 | Indirect | Duplicate filing |
| Dec 16, 2025 | Common Shares | SSaleDisposed | −642,282 | $23.08 | −$14,823,868.56 | 17,130,445 | Indirect | Duplicate filing |
| Dec 17, 2025 | Common Shares | SSaleDisposed | −432,718 | $23.05 | −$9,974,149.9 | 16,697,727 | Indirect | Duplicate filing |
| Dec 17, 2025 | Common Shares | SSaleDisposed | −155,076 | $23.02 | −$3,569,849.52 | 16,542,651 | Indirect | Duplicate filing |
| Dec 17, 2025 | Common Shares | SSaleDisposed | −189,538 | $23.17 | −$4,391,595.46 | 16,353,113 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.